Article ; Online: Holmium laser with MOSES technology (MoLEP) vs Thulium fiber laser enucleation of the prostate (ThuFLEP) in a real-world setting. Mid-term outcomes from a multicenter propensity score analysis.
2023 Volume 41, Issue 11, Page(s) 2915–2923
Abstract: Purpose: To compare Holmium laser with MOSES technology (MoLEP) and Thulium fiber laser ...
Abstract | Purpose: To compare Holmium laser with MOSES technology (MoLEP) and Thulium fiber laser enucleation of the prostate (ThuFLEP) in terms of surgical and functional outcomes. Methods: We performed a retrospective analysis of all patients who underwent either procedure in five centers (January 2020-January 2022). Exclusion criteria: previous urethral/prostatic surgery, radiotherapy, concomitant surgery. Propensity score matching (PSM) analysis was performed to adjust for the bias inherent to the different characteristics at baseline. Differences between procedures were estimated using Firth Penalized Likelihood regression for International prostate symptom score (IPSS), quality of life (QL), maximum flow rate (Qmax). Results: PSM retrieved 118 patients in each group. Baseline characteristics were similar except for PSA and number of men on indwelling catheter (higher in MoLEP group). Median surgical time was significantly longer in the MoLEP group despite the enucleation and morcellation times being similar. Median catheter dwelling time and postoperative length of stay were similar. Most of the early complications were Clavien ≤ 2 grade. There were only two Clavien grade 3 complications (one for each group), one grade 4 in MoLEP group. Rate and type of early and persistent incontinence (> 3 months) were similar. At 12-month, proportion of patients reaching a decrease (Δ) of IPSS ≥ 18 from baseline was significantly larger in MoLEP group, with no significant difference in ΔQmax > 12 ml/sec and ΔQL ≥ -3. Conclusion: MoLEP and ThuFLEP were safe and efficacious procedures with similar short-term operative and functional outcomes. At 1-year, MoLEP patients had a sustained reduction of IPPS score. |
---|---|
MeSH term(s) | Male ; Humans ; Prostate/surgery ; Lasers, Solid-State/therapeutic use ; Thulium/therapeutic use ; Prostatic Hyperplasia/surgery ; Quality of Life ; Retrospective Studies ; Propensity Score ; Treatment Outcome ; Laser Therapy/methods |
Chemical Substances | Thulium (8RKC5ATI4P) |
Language | English |
Publishing date | 2023-07-29 |
Publishing country | Germany |
Document type | Multicenter Study ; Journal Article |
ZDB-ID | 380333-8 |
ISSN | 1433-8726 ; 0724-4983 |
ISSN (online) | 1433-8726 |
ISSN | 0724-4983 |
DOI | 10.1007/s00345-023-04524-7 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1832: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.